ANIP
Price
$58.46
Change
+$0.96 (+1.67%)
Updated
Jan 17 closing price
Capitalization
1.43B
39 days until earnings call
DERM
Price
$3.66
Change
-$0.13 (-3.43%)
Updated
Jan 17 closing price
Capitalization
73.35M
60 days until earnings call
Ad is loading...

ANIP vs DERM

Header iconANIP vs DERM Comparison
Open Charts ANIP vs DERMBanner chart's image
ANI Pharmaceuticals
Price$58.46
Change+$0.96 (+1.67%)
Volume$302.52K
Capitalization1.43B
Journey Medical
Price$3.66
Change-$0.13 (-3.43%)
Volume$51.89K
Capitalization73.35M
ANIP vs DERM Comparison Chart
Loading...
ANIP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DERM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANIP vs. DERM commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANIP is a Hold and DERM is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (ANIP: $58.46 vs. DERM: $3.66)
Brand notoriety: ANIP: Not notable vs. DERM: Notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ANIP: 117% vs. DERM: 61%
Market capitalization -- ANIP: $1.43B vs. DERM: $73.35M
ANIP [@Pharmaceuticals: Other] is valued at $1.43B. DERM’s [@Pharmaceuticals: Other] market capitalization is $73.35M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.54B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANIP’s FA Score shows that 0 FA rating(s) are green whileDERM’s FA Score has 0 green FA rating(s).

  • ANIP’s FA Score: 0 green, 5 red.
  • DERM’s FA Score: 0 green, 5 red.
According to our system of comparison, DERM is a better buy in the long-term than ANIP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANIP’s TA Score shows that 3 TA indicator(s) are bullish while DERM’s TA Score has 3 bullish TA indicator(s).

  • ANIP’s TA Score: 3 bullish, 2 bearish.
  • DERM’s TA Score: 3 bullish, 2 bearish.
According to our system of comparison, both ANIP and DERM are a good buy in the short-term.

Price Growth

ANIP (@Pharmaceuticals: Other) experienced а +6.21% price change this week, while DERM (@Pharmaceuticals: Other) price change was -4.44% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.23%. For the same industry, the average monthly price growth was +2.88%, and the average quarterly price growth was -9.56%.

Reported Earning Dates

ANIP is expected to report earnings on May 08, 2025.

DERM is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+0.23% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ANIP($1.43B) has a higher market cap than DERM($73.4M). ANIP YTD gains are higher at: 5.753 vs. DERM (-6.394). ANIP has higher annual earnings (EBITDA): 107M vs. DERM (-5.69M). ANIP has more cash in the bank: 221M vs. DERM (24.7M). DERM has less debt than ANIP: DERM (131K) vs ANIP (286M). ANIP has higher revenues than DERM: ANIP (487M) vs DERM (79.9M).
ANIPDERMANIP / DERM
Capitalization1.43B73.4M1,948%
EBITDA107M-5.69M-1,881%
Gain YTD5.753-6.394-90%
P/E Ratio79.85N/A-
Revenue487M79.9M610%
Total Cash221M24.7M895%
Total Debt286M131K218,321%
FUNDAMENTALS RATINGS
ANIP vs DERM: Fundamental Ratings
ANIP
DERM
OUTLOOK RATING
1..100
750
VALUATION
overvalued / fair valued / undervalued
1..100
89
Overvalued
81
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9099
PRICE GROWTH RATING
1..100
5591
P/E GROWTH RATING
1..100
9550
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

DERM's Valuation (81) in the Biotechnology industry is in the same range as ANIP (89) in the Pharmaceuticals Other industry. This means that DERM’s stock grew similarly to ANIP’s over the last 12 months.

DERM's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ANIP (100) in the Pharmaceuticals Other industry. This means that DERM’s stock grew similarly to ANIP’s over the last 12 months.

ANIP's SMR Rating (90) in the Pharmaceuticals Other industry is in the same range as DERM (99) in the Biotechnology industry. This means that ANIP’s stock grew similarly to DERM’s over the last 12 months.

ANIP's Price Growth Rating (55) in the Pharmaceuticals Other industry is somewhat better than the same rating for DERM (91) in the Biotechnology industry. This means that ANIP’s stock grew somewhat faster than DERM’s over the last 12 months.

DERM's P/E Growth Rating (50) in the Biotechnology industry is somewhat better than the same rating for ANIP (95) in the Pharmaceuticals Other industry. This means that DERM’s stock grew somewhat faster than ANIP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ANIPDERM
RSI
ODDS (%)
N/A
Bullish Trend 5 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 5 days ago
83%
Bullish Trend 5 days ago
86%
Momentum
ODDS (%)
Bearish Trend 5 days ago
76%
N/A
MACD
ODDS (%)
Bullish Trend 5 days ago
68%
N/A
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
73%
Bearish Trend 5 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
75%
Bearish Trend 5 days ago
90%
Advances
ODDS (%)
Bullish Trend 16 days ago
72%
Bullish Trend 13 days ago
84%
Declines
ODDS (%)
Bearish Trend 11 days ago
72%
Bearish Trend 5 days ago
86%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
N/A
Bearish Trend 5 days ago
89%
View a ticker or compare two or three
Ad is loading...
ANIP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DERM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X104462.0400004705.133000
+4.72%
Bitcoin cryptocurrency
TSLA426.5012.68
+3.06%
Tesla
SPY597.585.94
+1.00%
SPDR® S&P 500® ETF Trust
AAPL229.981.72
+0.75%
Apple
GME27.51-0.21
-0.76%
GameStop Corp

ANIP and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANIP has been loosely correlated with DRRX. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if ANIP jumps, then DRRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANIP
1D Price
Change %
ANIP100%
+1.67%
DRRX - ANIP
38%
Loosely correlated
+2.15%
PAHC - ANIP
30%
Poorly correlated
-0.53%
ORGO - ANIP
26%
Poorly correlated
+0.30%
PBH - ANIP
25%
Poorly correlated
+0.38%
AMRX - ANIP
24%
Poorly correlated
-0.60%
More

DERM and

Correlation & Price change

A.I.dvisor tells us that DERM and SWGHF have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DERM and SWGHF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DERM
1D Price
Change %
DERM100%
-3.43%
SWGHF - DERM
25%
Poorly correlated
N/A
ANIP - DERM
10%
Poorly correlated
+1.67%
KMDA - DERM
9%
Poorly correlated
+0.99%
COLL - DERM
8%
Poorly correlated
-0.33%
RDHL - DERM
7%
Poorly correlated
-0.99%
More